TwinBeech Capital’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
Other funds holding RCUS
TwinBeech Capital's RCUS Position: Q3 2026 in Review
TwinBeech Capital opened a new position in Arcus Biosciences (RCUS) in Q3 2026: 23,600 shares worth $610K. The stake represents 0.14% of the portfolio and ranks #204 among its holdings. This is a return to the name: TwinBeech Capital previously reported a position in RCUS as recently as Q3 2023.
TwinBeech Capital first reported a position in RCUS in Q1 2022 and has held it in 4 quarters since. The position peaked at $2.68M in Q4 2022. 244 funds tracked by Wall St. Rank hold RCUS as of Q3 2026.
- TwinBeech Capital held 23,600 shares of Arcus Biosciences worth $610K as of Q3 2026.
- Arcus Biosciences was a new TwinBeech Capital position in Q3 2026.
- Arcus Biosciences made up 0.14% of TwinBeech Capital's portfolio in Q3 2026, its #204 holding.
- TwinBeech Capital first reported a position in Arcus Biosciences in Q1 2022 and has held it in 4 quarters since.
- TwinBeech Capital's Arcus Biosciences position peaked at $2.68M in Q4 2022.
- 244 funds tracked by Wall St. Rank held Arcus Biosciences as of Q3 2026.
Based on TwinBeech Capital's 13F filing for Q3 2026, filed 16 Nov 2026.